Vivos Therapeutics, Inc.
VVOSNasdaqCIK 1716166HealthcareFiscal year ends Dec 31
Reports and events: 134 filings
Newest first, by EDGAR acceptance time (Eastern). Each filing’s page lists its documents on sec.gov and, for 10-K and 10-Q reports, the extracted sections.
What the forms are: 10-K, 10-Q, 8-K, Form 4, DEF 14A, Schedule 13D, Schedule 13G, amendments, accession numbers.
| Filed | Form | What it is | Accession number |
|---|---|---|---|
| 2026-10-2107:00 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001493152-26-047841 |
| 2026-10-1916:49 ET | 8-K | 1.01 Entry into a material agreement; 2.01 Completion of an acquisition or disposition; 3.02 Unregistered sale of equity; 3.03 Change to security holders’ rights; 5.03 Amendment to articles or bylaws; 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001493152-26-047601 |
| 2026-10-1508:45 ET | 8-K | 1.01 Entry into a material agreement; 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001493152-26-047158 |
| 2026-10-0121:54 ET | 8-K | 4.01 Change of auditor; 9.01 Financial statements and exhibits | 0001493152-26-045193 |
| 2026-09-0817:29 ET | 8-K/A | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 9.01 Financial statements and exhibits | 0001493152-26-041807 |
| 2026-09-0818:26 ET | 8-K | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 9.01 Financial statements and exhibits | 0001493152-26-041616 |
| 2026-08-2117:30 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001493152-26-039736 |
| 2026-08-1416:07 ET | 10-Q | Quarterly reportPeriod 2026-06-30 | 0001493152-26-038336 |
| 2026-08-1117:02 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001493152-26-037173 |
| 2026-08-0317:29 ET | 8-K | 1.01 Entry into a material agreement; 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001493152-26-035867 |
| 2026-07-1517:07 ET | SCHEDULE 13D | Ownership report, active investor | 0001104659-26-083931 |
| 2026-07-0717:29 ET | 8-K | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 5.03 Amendment to articles or bylaws; 9.01 Financial statements and exhibits | 0001493152-26-032387 |
| 2026-06-2517:22 ET | 8-K | 1.01 Entry into a material agreement; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001493152-26-030190 |
| 2026-06-1617:03 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001493152-26-028912 |
| 2026-06-1619:44 ET | 8-K | 1.01 Entry into a material agreement; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001493152-26-028775 |
| 2026-06-0808:30 ET | 8-K | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 3.01 Delisting notice; 3.02 Unregistered sale of equity; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001493152-26-027641 |
| 2026-05-2017:05 ET | 10-Q | Quarterly reportPeriod 2026-03-31 | 0001493152-26-024650 |
| 2026-04-2216:25 ET | 8-K | 3.01 Delisting notice | 0001493152-26-018562 |
| 2026-04-1517:15 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001493152-26-016865 |
| 2026-04-1517:00 ET | 10-K | Annual reportPeriod 2025-12-31 | 0001493152-26-016854 |
| 2026-04-0316:05 ET | 8-K | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 9.01 Financial statements and exhibits | 0001493152-26-015132 |
| 2026-04-0218:32 ET | SCHEDULE 13D | Ownership report, active investor | 0001104659-26-039298 |
| 2026-02-0616:05 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0001493152-26-005554 |
| 2026-01-2016:05 ET | 8-K | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 9.01 Financial statements and exhibits | 0001493152-26-002844 |
| 2026-01-1616:05 ET | 8-K | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 3.02 Unregistered sale of equity; 9.01 Financial statements and exhibits | 0001493152-26-002557 |
| 2025-12-1717:54 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001493152-25-028019 |
| 2025-12-0517:12 ET | 8-K | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 9.01 Financial statements and exhibits | 0001493152-25-026438 |
| 2025-11-1916:45 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001493152-25-024289 |
| 2025-11-1916:06 ET | 10-Q | Quarterly reportPeriod 2025-09-30 | 0001493152-25-024253 |
| 2025-11-0416:58 ET | 8-K | 5.07 Shareholder vote results | 0001493152-25-020750 |
| 2025-10-2417:20 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001493152-25-019359 |
| 2025-09-2919:42 ET | DEF 14A | Proxy statementPeriod 2025-09-26 | 0001493152-25-015837 |
| 2025-09-1820:41 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001493152-25-013953 |
| 2025-09-1216:52 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001641172-25-027210 |
| 2025-08-2516:46 ET | 8-K/A | 2.01 Completion of an acquisition or disposition; 8.01 Other events; 9.01 Financial statements and exhibits | 0001641172-25-025396 |
| 2025-08-2016:05 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001641172-25-024979 |
| 2025-08-1916:06 ET | 10-Q | Quarterly reportPeriod 2025-06-30 | 0001641172-25-024832 |
| 2025-06-1619:57 ET | SCHEDULE 13D | Ownership report, active investor | 0002049575-25-000002 |
| 2025-06-1317:02 ET | 8-K | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 3.02 Unregistered sale of equity; 8.01 Other events; 9.01 Financial statements and exhibits | 0001641172-25-015115 |
| 2025-06-0617:19 ET | 8-K | 4.01 Change of auditor; 9.01 Financial statements and exhibits | 0001641172-25-014118 |
| 2025-05-2308:00 ET | 8-K | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 3.02 Unregistered sale of equity; 9.01 Financial statements and exhibits | 0001641172-25-012181 |
| 2025-05-1517:25 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001641172-25-011084 |
| 2025-05-1516:05 ET | 10-Q | Quarterly reportPeriod 2025-03-31 | 0001641172-25-010874 |
| 2025-04-1708:30 ET | 8-K | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0001641172-25-005165 |
| 2025-03-3117:29 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001641172-25-001895 |
| 2025-03-3116:20 ET | 10-K | Annual reportPeriod 2024-12-31 | 0001641172-25-001750 |
| 2025-02-1407:55 ET | 8-K | 1.01 Entry into a material agreement; 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001493152-25-006584 |
| 2025-01-2906:04 ET | S-1/A | Registration statement, amended | 0001493152-25-004057 |
| 2025-01-2206:09 ET | S-1 | Registration statement | 0001493152-25-003115 |
| 2024-12-2317:29 ET | 8-K | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 8.01 Other events; 9.01 Financial statements and exhibits | 0001493152-24-051890 |
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 29, 2026, 15:56 ET. Listed shows no prices and gives no investment advice.